TEVJF Teva Pharmaceutical Industries Ltd

Pharmaceutical Preparations · NYSE · SEC EDGAR official

Market Value*

$18.16B

Revenue (FY)

$17.26B 2025-12-31

Net Income (FY)

$1.41B

P/E (float-based)

12.9

Israeli pharmaceutical company.

Revenue History

*Market value = public float disclosed in latest 10-K filing · CIK 818686 · SEC filings · revenue ranking · home